scispace - formally typeset
D

Douglas A. Melton

Researcher at Harvard University

Publications -  299
Citations -  73978

Douglas A. Melton is an academic researcher from Harvard University. The author has contributed to research in topics: Stem cell & Cellular differentiation. The author has an hindex of 120, co-authored 291 publications receiving 70103 citations. Previous affiliations of Douglas A. Melton include Broad Institute & Fairchild Semiconductor International, Inc..

Papers
More filters
Journal ArticleDOI

Follistatin, an antagonist of activin, is expressed in the Spemann organizer and displays direct neuralizing activity

TL;DR: It is shown that the expression of a dominant negative activin receptor can convert prospective ectoderm into neural tissue, which suggests that activin is an inhibitor of neuralization, and follistatin RNA and protein are able to block the activity of activin in embryonic explants.
Journal ArticleDOI

Notch signaling controls multiple steps of pancreatic differentiation

TL;DR: A modular transgenic system to heritably activate mouse Notch1 in multiple types of progenitors and differentiated cells finds that misexpression of activated Notch in Pdx1-expressing progenitor cells prevents differentiation of both exocrine and endocrine lineages.
Book ChapterDOI

In vitro RNA synthesis with SP6 RNA polymerase.

TL;DR: The chapter describes the use of in vitro transcription systems for the synthesis of RNAs for use as substrates and hybridization probes and discusses the advantages of the technique and several associated problems.
Journal ArticleDOI

Notochord repression of endodermal Sonic hedgehog permits pancreas development

TL;DR: Activin-betaB and FGF2 are identified as notochord factors that can repress endodermal SHH and thereby permit expression of pancreas genes including Pdx1 and insulin.
Journal ArticleDOI

Generation of pluripotent stem cells from patients with type 1 diabetes.

TL;DR: It is shown that induced pluripotent stem (iPS) cells can be generated from patients with T1D by reprogramming their adult fibroblasts with three transcription factors (OCT4, SOX2, KLF4).